DANIA BEACH, Fla., September 01, 2021--(BUSINESS WIRE)--Chewy, Inc. (NYSE: CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere,...
Quarter
Updates FY 2021 revenue outlook to range of $414 million to $415 million from $408 million following the acquisition of...
Announcing first solid tumor indication in HPV associated-malignancies – NEXI-003Advancing two lead product candidates in Phase 1/2 clinical trials Additional...
– Noted Constructive Major-Line Data From Pivotal PHYOX™2 Scientific Trial of Nedosiran Investigational GalXC™ RNAi Treatment for Therapy of Most...
- IPO raised an aggregate of approximately $149.1 million in gross proceeds- Strong cash position of $198.6 million to be...
Doximity cofounder and CEO Jeff Tangney. doximity Although Doximity CEO Jeff Tangney thinks we are even now in the “early...
Total Revenue of $13.0 Million in 2Q 2021; TAZVERIK® Net Product Revenues of $8.0 MillionRevised Commercial Strategy and Operating Plan...
FULL YEAR 2021 OUTLOOK REFLECTS OUTPERFORMANCE IN ALL SEGMENTS- Q2 2021 consolidated net revenue increased $617 million (+208%) to $914...
Conference Call on Monday, August 9, 2021, at 4pm ETRESTON, Va., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ:...
RAPIDe-1, Phase 2 on-demand study of PHVS416 for the treatment of HAE attacks expanding to US, expected to report data...
